Literature DB >> 21451815

Modeling cholesterol metabolism by gene expression profiling in the hippocampus.

Christopher M Valdez1, Clyde F Phelix, Mark A Smith, George Perry, Fidel Santamaria.   

Abstract

An important part of the challenge of building models of biochemical reactions is determining reaction rate constants that transform substrates into products. We present a method to derive enzymatic kinetic values from mRNA expression levels for modeling biological networks without requiring further tuning. The core metabolic reactions of cholesterol in the brain, particularly in the hippocampus, were simulated. To build the model the baseline mRNA expression levels of genes involved in cholesterol metabolism were obtained from the Allen Mouse Brain Atlas. The model is capable of replicating the trends of relative cholesterol levels in Alzheimer's and Huntington's diseases; and reliably simulated SLOS, desmosterolosis, and Dhcr14/Lbr knockout studies. A sensitivity analysis correctly uncovers the Hmgcr, Idi2 and Fdft1 sites that regulate cholesterol homeostasis. Overall, our model and methodology can be used to pinpoint key reactions, which, upon manipulation, may predict altered cholesterol levels and reveal insights into potential drug therapy targets under diseased conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451815      PMCID: PMC4105148          DOI: 10.1039/c0mb00282h

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  85 in total

1.  Anomalous diffusion in Purkinje cell dendrites caused by spines.

Authors:  Fidel Santamaria; Stefan Wils; Erik De Schutter; George J Augustine
Journal:  Neuron       Date:  2006-11-22       Impact factor: 17.173

2.  Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

Authors:  Tiina J Kotti; Denise M O Ramirez; Brad E Pfeiffer; Kimberly M Huber; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  How can biochemical reactions within cells differ from those in test tubes?

Authors:  Allen P Minton
Journal:  J Cell Sci       Date:  2006-07-15       Impact factor: 5.285

4.  Reduced risk of incident AD with elective statin use in a clinical trial cohort.

Authors:  D Larry Sparks; Richard J Kryscio; Marwan N Sabbagh; Donald J Connor; Lisa M Sparks; Carolyn Liebsack
Journal:  Curr Alzheimer Res       Date:  2008-08       Impact factor: 3.498

5.  Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.

Authors:  John P Cogswell; James Ward; Ian A Taylor; Michelle Waters; Yunling Shi; Brian Cannon; Kevin Kelnar; Jon Kemppainen; David Brown; Caifu Chen; Rab K Prinjha; Jill C Richardson; Ann M Saunders; Allen D Roses; Cynthia A Richards
Journal:  J Alzheimers Dis       Date:  2008-05       Impact factor: 4.472

6.  Mathematical analysis of models for reaction kinetics in intracellular environments.

Authors:  Zeljko Bajzer; Miljenko Huzak; Kevin L Neff; Franklyn G Prendergast
Journal:  Math Biosci       Date:  2008-05-24       Impact factor: 2.144

7.  Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo.

Authors:  Eugenia Trushina; Raman Deep Singh; Roy B Dyer; Sheng Cao; Vijay H Shah; Robert G Parton; Richard E Pagano; Cynthia T McMurray
Journal:  Hum Mol Genet       Date:  2006-12-15       Impact factor: 6.150

8.  Regional and cellular gene expression changes in human Huntington's disease brain.

Authors:  Angela Hodges; Andrew D Strand; Aaron K Aragaki; Alexandre Kuhn; Thierry Sengstag; Gareth Hughes; Lyn A Elliston; Cathy Hartog; Darlene R Goldstein; Doris Thu; Zane R Hollingsworth; Francois Collin; Beth Synek; Peter A Holmans; Anne B Young; Nancy S Wexler; Mauro Delorenzi; Charles Kooperberg; Sarah J Augood; Richard L M Faull; James M Olson; Lesley Jones; Ruth Luthi-Carter
Journal:  Hum Mol Genet       Date:  2006-02-08       Impact factor: 6.150

Review 9.  Altered lipid metabolism in brain injury and disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Subcell Biochem       Date:  2008

Review 10.  Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?

Authors:  Marta Valenza; Elena Cattaneo
Journal:  Prog Neurobiol       Date:  2006-10-25       Impact factor: 11.685

View more
  2 in total

1.  Tracking Effects of SIL1 Increase: Taking a Closer Look Beyond the Consequences of Elevated Expression Level.

Authors:  Thomas Labisch; Stephan Buchkremer; Vietxuan Phan; Laxmikanth Kollipara; Christian Gatz; Chris Lentz; Kay Nolte; Jörg Vervoorts; José Andrés González Coraspe; Albert Sickmann; Stephanie Carr; René P Zahedi; Joachim Weis; Andreas Roos
Journal:  Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.590

2.  Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease.

Authors:  Michael A Castello; John David Jeppson; Salvador Soriano
Journal:  BMC Neurol       Date:  2014-09-02       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.